CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Although we have previously shown that CD34+38− CML cells express high levels of BCR-ABL 12, our current data either suggest that BCR-ABL is not fully active in this population of primitive cells or that FOXO activity provides the dominant signal, thus providing an explanation for their intrinsic quiescence.